Non-vitamin K antagonist oral anti-coagulation agents (NOACs) for the treatment and secondary prevention of venous thromboembolism

Published on 05 Feb 2018
Last Updated on 06 Feb 2026

Non-vitamin K antagonist oral anti-coagulation agents (NOACs) for the treatment and secondary prevention of venous thromboembolism Guidance is outdated and has been withdrawn on 6 February 2026.

NOACs for the treatment and secondary prevention of venous thromboembolism (Withdrawn 6 Feb 2026) [PDF, 130 KB]

PES Anticoagulants to treat and prevent blood clots (Withdrawn 6 Feb 2026) [PDF, 141 KB]